GleamWall
中文EN

HRGN Harvard Apparatus Regenerative Technology, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1563665 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY35.1%
TTM net income YoY1.2%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin7.5%
Operating margin-643.0%
Net margin-642.0%
FCF margin—
EBITDA margin-642.6%

Returns

ROE-621.0%
ROA-225.6%
ROIC (approx.)—
Asset turnover0.35x

Leverage & solvency

Liabilities / assets83.5%
Debt / equity0.00x
Current ratio0.87x
Interest coverage-269.00x

Cash quality & payout

Operating cash flow / net income0.43x
Accruals ratio-127.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$704,000$430,000
Cost of revenue$646,000$270,000
Gross profit$58,000$160,000
R&D expense$2.65M$2.31M
SG&A expense$4.25M$5.02M
Operating income-$6.92M-$7.73M
Interest expense$8,000$38,000
Pretax income-$6.87M-$7.73M
Income tax$0$0
Net income-$6.87M-$7.73M
EBITDA-$6.91M-$7.71M
EPS (basic)-0.42-0.52
EPS (diluted)——
Balance sheet
Cash & equivalents$1.35M$2.49M
Receivables$16,000$231,000
Inventory$16,000$80,000
Current assets$1.83M$3.23M
PP&E, net$6,000$11,000
Total assets$2.68M$4.44M
Current liabilities$1.53M$1.02M
Total liabilities$1.62M$1.22M
Shareholders' equity$1.06M$3.22M
Shares outstanding17.58M15.92M
Cash flow statement
Operating cash flow-$3.83M-$4.85M
Capital expenditure—$0
Free cash flow—-$4.85M
Investing cash flow—$0
Financing cash flow$2.70M$6.91M
Depreciation & amortization$5,000$14,000
Stock-based compensation$2.01M$2.40M

Free plan shows the latest 2 periods; Pro shows all 14 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.